BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16629937)

  • 1. Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.
    Wong CH; Chua CJ; Liam CK; Goh KL
    Aliment Pharmacol Ther; 2006 May; 23(9):1321-7. PubMed ID: 16629937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications.
    Sandur V; Murugesh M; Banait V; Rathi PM; Bhatia SJ; Joshi JM; Kate A
    J Postgrad Med; 2014; 60(3):282-6. PubMed ID: 25121368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
    Qua CS; Wong CH; Gopala K; Goh KL
    Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
    Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
    Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease.
    Shimizu Y; Dobashi K; Kobayashi S; Ohki I; Tokushima M; Kusano M; Kawamura O; Shimoyama Y; Utsugi M; Sunaga N; Ishizuka T; Mori M
    Tohoku J Exp Med; 2006 Jul; 209(3):181-9. PubMed ID: 16778364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relation of GERD, bronchial asthma and the upper respiratory tract].
    Matyásová Z; Novotná B; Matulová M; Dolina J; Kroupa R; Láníková Z; Znojil V; Hep A; Dite P
    Vnitr Lek; 2005 Dec; 51(12):1341-50. PubMed ID: 16430100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
    Milkes D; Gerson LB; Triadafilopoulos G
    Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease.
    Shimizu Y; Dobashi K; Zhao JJ; Kawata T; Ono A; Yanagitani N; Kaira K; Utsugi M; Hisada T; Ishizuka T; Mori M
    Respiration; 2007; 74(5):558-64. PubMed ID: 17389779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.
    Levin TR; Sperling RM; McQuaid KR
    Am J Gastroenterol; 1998 Jul; 93(7):1060-3. PubMed ID: 9672330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.
    Littner MR; Leung FW; Ballard ED; Huang B; Samra NK;
    Chest; 2005 Sep; 128(3):1128-35. PubMed ID: 16162697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [GERD (gastroesophageal reflux disease)].
    Dobashi K
    Nihon Rinsho; 2001 Oct; 59(10):2045-50. PubMed ID: 11676152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease.
    Jones R; Liker HR; Ducrotté P
    Int J Clin Pract; 2007 Aug; 61(8):1301-7. PubMed ID: 17590216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
    Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
    Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias.
    Cuomo R; De Giorgi F; Adinolfi L; Sarnelli G; Loffredo F; Efficie E; Verde C; Savarese MF; Usai P; Budillon G
    Aliment Pharmacol Ther; 2006 Jul; 24(2):361-70. PubMed ID: 16842463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.